CT Corporation experts will discuss the complex regulatory challenges facing manufacturers and distributors
Manufacturers and distributors operating within the pharmaceutical industry must contend with a high-stakes regulatory environment where failure to obtain or renew a license can result in severe fines or even criminal prosecution. Wolters Kluwer CT Corporation will host a webinar – Healthcare and Pharmaceutical Industry Business Licensing – on October 19 at 1pm ET that is designed to help entities navigate the myriad of conflicting licensing requirements they could encounter from state-to-state.
CT Corporation experts David Yount, Vice President and Head of Business Licenses, and Hans Howk, Content Manager, will provide an overview of licensing requirements spanning wholesale drug distributors, drug manufacturers, third-party logistics providers, and pharmacies. Webinar attendees can also expect a “fireside chat” exploring the implications of the Drug Supply Chain Security Act (DSCSA), which established requirements for tracing prescription drug products through the pharmaceutical supply distribution chain.
Both Yount and Howk joined CT Corporation following the company’s successful acquisition of business license services provider LicenseLogix in 2021. Yount runs the company’s business licensing arm and has overseen a significant expansion in CT Corporation’s licensing services and team, where Howk consults on issues such as legal industry nuances, regulations pertaining to business law, and searching and synthesizing statutes.
